Crinetics Pharmaceuticals, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US22663K1079
USD
44.79
12.51 (38.75%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1237140,
    "name": "Crinetics Pharmaceuticals, Inc.",
    "stock_name": "Crinetics Pharmaceuticals, Inc.",
    "full_name": "Crinetics Pharmaceuticals, Inc.",
    "name_url": "stocks-analysis/crinetics-pharmaceuticals-inc",
    "exchange": 1,
    "exchangecode": "NAS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "44.79",
    "chg": 12.51,
    "chgp": "38.75%",
    "dir": 1,
    "prev_price": "32.28",
    "mcapval": "5,218.29",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2305,
    "indexname": "S&P 500",
    "isin": "US22663K1079",
    "curr_date": "Feb 05",
    "curr_time": "",
    "bse_nse_vol": "2.09 M",
    "exc_status": "Active",
    "traded_date": "Feb 05, 2026",
    "traded_date_str": "2026 02 05",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/crinetics-pharmaceuticals-inc-1237140-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Crinetics Pharmaceuticals Hits Day Low of $38.81 Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/crinetics-pharmaceuticals-hits-day-low-of-3881-amid-price-pressure-3686576",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/CrineticsPharma_priceRelatedfactors_3686576.png",
        "date": "2025-11-10 17:53:56",
        "description": "Crinetics Pharmaceuticals, Inc. has faced significant challenges, with a notable decline in stock performance and ongoing financial difficulties, including 25 consecutive quarters of negative results. Despite a substantial increase over the past three years, the company's recent trajectory and year-to-date performance raise concerns about its profitability and market position."
      }
    ],
    "total": 16,
    "sid": "1237140",
    "stock_news_url": "https://www.marketsmojo.com/news/crinetics-pharmaceuticals-inc-1237140"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available